Advocacy

Protecting the Integrated Model of Care

High-quality, integrated care delivered in the independent medical practice setting is worthy of protection as an alternative to care that is often more costly when furnished in the hospital setting. Read more...

Saving the In Office Ancillary Service Exception (IOASE)

Integrated models of care allow for better coordination across specialties, translating into higher quality, lower cost and more accessible care for patients. Read more...

Pathology Services Utilization

Recent data, including 2009-2013 Medicare data relating to the cost and utilization of anatomic pathology (AP) services, demonstrates that the GAO report fails to tell the full story about cost and utilization. Read more...

Recent Advocacy

March 12, 2022

Independent Healthcare Grants and Charitable Donations (Abbvie)

The Independent Healthcare Grants and Charitable Donations seek to help further education around current, new and emerging sciences and standards of care, as we know they are key to the patient experience.
Continue Reading >>

March 12, 2022

Community Grant Program (Walmart Foundation)

The Walmart Community Grant Program provides grants to support the unique needs of local communities in the service areas of Walmart and Sam’s Club stores.
Continue Reading >>

March 10, 2022

High School Outreach Curriculum and Blueprint for Session Titled: The Tools of a Gastroenterology Practice (Capital Digestive Care)

Capital Digestive Care has established a pipeline program to help students develop an interest in medical careers by providing exposure to gastroenterology physicians and discussion of diversity and equity in medicine.
Continue Reading >>

February 24, 2022

Pioneering Ideas: Exploring the Future to Build a Culture of Health (Robert Wood Johnson Foundation)

Pioneering Ideas: Exploring the Future to Build a Culture of Health seeks proposals that are primed to influence health equity in the future.
Continue Reading >>

February 15, 2022

DHPA Requests Safe Harbor for Copay Coupons for Drugs with no Lower-Cost Alternative

DHPA was among 18 provider and patient advocacy groups that signed onto a letter requesting that the Office of the Inspector General (OIG) issue new guidance indicating that manufacturer copay assistance to federal health program beneficiaries is a violation of the Anti-Kickback Statute when there is a less expensive and equally effective generic or interchangeable […]
Continue Reading >>